Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 October 2008

Mupirocin resistance among Iranian isolates of Staphylococcus aureus

Horieh SaderiABCDEFG, Parviz OwliaACDE, Mehri HabibiBCF

Med Sci Monit 2008; 14(10): BR210-213 :: ID: 869408


The topical agent mupirocin plays a crucial role in strategies designed to control outbreaks of methicillin-resistant Staphylococcus aureus. The rate of high- and low-level mupirocin resistance among S. aureus strains from Iranian hospitals is not known.
Material and Method
Two hundred twenty-two nonduplicate S. aureus strains consecutively isolated in four university hospitals in Tehran, Iran, were tested for mupirocin susceptibility by disc diffusion agar method and minimum inhibitory concentration (MIC) determination by the E-test. Susceptibility to 16 other antimicrobial agents was also determined.
With the disc diffusion agar method, the majority of strains (97.3%) were susceptible to mupirocin and only 2.7% were resistant. The S. aureus strains showed high resistance (>50%) to most antibiotics, including penicillin G, ampicillin-sulbactam, oxacillin, cefoxitin, ciprofloxacin, erythromycin, tetracycline, clindamycin, gentamicin, and rifampicin, but resistance to linezolid, chloramphenicol, cotrimoxazole, and quinupristin/dalfopristin was low and no isolate was resistant to vancomycin. In the E-test, six strains had MICs of >4 mg/l, i.e. five strains had MICs of 8-256 mg/l (low-level mupirocin resistance) and one strain had 1024 mg/l (high-level mupirocin resistance). One strain was resistant to mupirocin in the disc diffusion agar method but showed sensitivity in the E-test (MIC: 0.94 mg/l). The mupirocin-resistant S. aureus isolates were all methicillin resistant and more resistant to the other antimicrobial agents compared with the mupirocin-susceptible strains.
This study is the first report about mupirocin resistance of S. aureus in Iranian hospitals.

Keywords: Mupirocin - pharmacology, Microbial Sensitivity Tests, Methicillin-Resistant Staphylococcus aureus - physiology, Iran, Methicillin Resistance - physiology, Drug Resistance, Multiple, Bacterial - physiology, Anti-Bacterial Agents - pharmacology

Add Comment 0 Comments


01 April 2024 : Editorial  

Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug Resistance

Dinah V. Parums

DOI: 10.12659/MSM.944600

Med Sci Monit 2024; 30:e944600


In Press

10 Apr 2024 : Clinical Research  

Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...

Med Sci Monit In Press; DOI: 10.12659/MSM.942612  

06 Mar 2024 : Clinical Research  

Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...

Med Sci Monit In Press; DOI: 10.12659/MSM.941102  

06 Mar 2024 : Clinical Research  

Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943884  

08 Mar 2024 : Clinical Research  

Evaluation of Foot Structure in Preschool Children Based on Body Mass

Med Sci Monit In Press; DOI: 10.12659/MSM.943765  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750